Shopping Cart
- Remove All
- Your shopping cart is currently empty
Tisotumab vedotin is an antibody-drug conjugate (ADC) that targets tissue factor (TF), combining a fully human monoclonal antibody against TF (TF-011) with the cytotoxic agent Monomethyl Auristatin E (MMAE), and exhibits potent antitumor activity in advanced or metastatic solid tumors [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | 1.472 € | 4-6 weeks | |
5 mg | 3.230 € | 4-6 weeks |
Description | Tisotumab vedotin is an antibody-drug conjugate (ADC) that targets tissue factor (TF), combining a fully human monoclonal antibody against TF (TF-011) with the cytotoxic agent Monomethyl Auristatin E (MMAE), and exhibits potent antitumor activity in advanced or metastatic solid tumors [1]. |
Cas No. | 1418731-10-8 |
Storage | keep away from direct sunlight | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.